Qun Li
Impact in
- Oncology top 10%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 23
- HER2/EGFR in Cancer Research 5
- Cancer-related Molecular Pathways 4
- Cancer Immunotherapy and Biomarkers 3
-
- Ubiquitin and proteasome pathways 3
- Co-authors
- John H. Martin (1 shared paper)Chao‐Yu Chen (1 shared paper)Daniel V. LaBarbera (1 shared paper)Mary Kay Harper (1 shared paper)Jerome Schaack (1 shared paper)Qiong Zhou (1 shared paper)Amit Kapadia (1 shared paper)Yong Gao (5 shared papers)
- Journals
- Journal of Clinical Oncology (8 papers)Frontiers in Oncology (3 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Biomaterials (2 papers)International Journal of Low-Carbon Technologies (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Qun Li
55 papers receiving 835 citations
Peers
Comparison fields: 5 of 108
- Oncology 253
- Cancer Research 83
- Molecular Biology 310
- Pharmaceutical Science 26
- Organic Chemistry 115
Countries citing papers authored by Qun Li
This map shows the geographic impact of Qun Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qun Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qun Li more than expected).
Fields of papers citing papers by Qun Li
This network shows the impact of papers produced by Qun Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qun Li. The network helps show where Qun Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Qun Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 115 | |
| 2 | 2003 | 67 | |
| 3 | 2005 | 64 | |
| 4 | 2018 | 48 | |
| 5 | 2011 | 44 | |
| 6 | 2016 | 43 | |
| 7 | 2022 | 39 | |
| 8 | 2001 | 37 | |
| 9 | 2023 | 34 | |
| 10 | 1998 | 33 | |
| 11 | 2014 | 26 | |
| 12 | 1999 | 25 | |
| 13 | 2016 | 22 | |
| 14 | 2021 | 19 | |
| 15 | 2020 | 18 | |
| 16 | 2018 | 18 | |
| 17 | 2022 | 15 | |
| 18 | 2019 | 15 | |
| 19 | 2019 | 13 | |
| 20 | 2009 | 13 |
About Qun Li
Qun Li is a scholar working on Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Epidemiology and Biomaterials, having authored 61 papers that have together received 858 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), HER2/EGFR in Cancer Research (5 papers), Nanoparticle-Based Drug Delivery (5 papers), Cancer-related Molecular Pathways (4 papers), Ubiquitin and proteasome pathways (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Hepatitis B Virus Studies (2 papers). The work is most often cited by research in Oncology (253 citations), Cancer Research (83 citations), Molecular Biology (310 citations), Pharmaceutical Science (26 citations) and Organic Chemistry (115 citations). Qun Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include John H. Martin, Chao‐Yu Chen, Daniel V. LaBarbera, Mary Kay Harper, Jerome Schaack, Qiong Zhou, Amit Kapadia, Yong Gao, Takafumi Iwatsubo and Takashi Usui. Their work appears in journals such as Journal of Clinical Oncology, Frontiers in Oncology, Bioorganic & Medicinal Chemistry Letters, Biomaterials and International Journal of Low-Carbon Technologies.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.